Please wait

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Talis Biomedical Corporation

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               

Security

Type

   Security
Class
Title		   Fee
Calculation
Rule		   Amount
Registered(1)(2)		   Proposed
Maximum
Offering
Price Per
Share(3)		   Proposed
Maximum
Aggregate
Offering Price		   Fee
Rate		   Amount of
Registration
Fee
               
Equity   Common Stock, par value $0.0001 per share   457(c)   37,489,210   $1.03   $38,613,886.30   0.0000927   $3,579.51
         
Total Offering Amounts      $38,613,886.30     $3,579.51
         
Total Fee Previously Paid          —  
         
Total Fee Offsets          $5,803.67(4)
         
Net Fee Due                $0

Table 2: Fee Offset Claims and Sources

 

                       
     Registrant
or Filer
Name		   Form
or
Filing
Type		   File
Number		   Initial
Filing
Date		   Filing
Date		   Fee Offset
Claimed		   Security
Type
Associated
with Fee
Offset
Claimed		   Security
Title
Associated
with Fee
Offset
Claimed		   Unsold
Securities
Associated
with Fee
Offset
Claimed		  

Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset

Claimed

   Fee Paid
with Fee
Offset
Source
 
Rule 457(p)
                       
Fee Offset Claims   Talis
Biomedical
Corporation		   Form S-3   333-263592   March 16, 2022     $3,579.51(4)   Equity   Common Stock   37,489,210   $62,606,980.70    
                       
Fee-Offset Sources   Talis
Biomedical
Corporation		   Form S-3   333-263592       March 16, 2022                       $5,803.67(4)

 

(1)

The shares of Common Stock, par value $0.0001 per share (“Common Stock”), of the Registrant will be offered for resale by the selling stockholder. Pursuant to Rule 416 under the Securities Act, this registration statement also covers any additional number of shares of Common Stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of Common Stock being registered pursuant to this registration statement.

(2)

Consists of an aggregate of 7,625,536 shares of the Common Stock, including an aggregate of 29,863,674 shares of Common Stock issuable upon the conversion of Series 1 convertible voting preferred stock, or if applicable, Series 2 convertible non-voting preferred stock, of the Registrant.

(3)

Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act of 1933, as amended (the “Securities Act”). The proposed maximum offering price per share and maximum aggregate offering price are calculated using the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on May 5, 2022, which date is within five business days prior to the filing of this registration statement.

(4)

On March 16, 2022, the Registrant filed a Registration Statement on Form S-3 (File No. 333-263592) (the “Prior Registration Statement”) with the SEC and paid a registration fee of $5,803.67. The Prior Registration Statement was withdrawn by filing a Form RW on April 22, 2022. No securities were sold under the Prior Registration Statement before it was withdrawn. Pursuant to Rule 457(p) under the Securities Act, the Registrant hereby offsets the total registration fee due under this Registration Statement against the fees previously paid in connection with the Prior Registration Statement. Accordingly, no additional registration fee is being paid in connection with the filing of this Registration Statement.